The Association between a Medical History of Depression and Gestational Diabetes in a Large Multi-ethnic Cohort in the United States by Bowers, Katherine et al.
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research CUNY Graduate School of Public Health & Health Policy 
2013 
The Association between a Medical History of Depression and 
Gestational Diabetes in a Large Multi-ethnic Cohort in the United 
States 
Katherine Bowers 
Cincinnati Children's Hospital Medical Center 
S. Katherine Laughon 
National Institutes of Health 
Sungduk Kim 
National Institutes of Health 
Sunni L. Mumford 
National Institutes of Health 
Jennifer Brite 
CUNY School of Public Health 
See next page for additional authors 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/sph_pubs/170 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
Authors 
Katherine Bowers, S. Katherine Laughon, Sungduk Kim, Sunni L. Mumford, Jennifer Brite, Michele Kiely, 
and Cuilin Zhang 
This article is available at CUNY Academic Works: https://academicworks.cuny.edu/sph_pubs/170 
The Association between a Medical History of Depression and
Gestational Diabetes in a Large Multi-ethnic Cohort in the United
States
Katherine Bowersa,b, S. Katherine Laughona, Sungduk Kima, Sunni L. Mumforda, Jennifer
Britec, Michele Kielya, and Cuilin Zhanga
aEunice Kennedy Shriver National Institute of Child Health and Human Development, National
Institutes of Health, Bethesda, MD
bCincinnati Children’s Hospital Medical Center, Division of Biostatistics and Epidemiology,
Cincinnati, OH
cSchool of Public Health, City University of New York, New York, NY
Abstract
Background: Both major depression and gestational diabetes mellitus (GDM) are prevalent
among women of reproductive age. Our objective was to determine whether a medical history of
depression is related to subsequent development of GDM.
Methods: The Consortium on Safe Labor was a US retrospective cohort study of 228 562 births
between 2002 and 2008. Exclusion criteria for the present analysis included multiple gestation
pregnancies (n = 5059), pre-existing diabetes (n = 12 771), deliveries <24 weeks (n = 395), site
GDM prevalence (<1%) (n = 20 721) and missing data on pre-pregnancy body mass index (BMI)
(n = 61 321). Using generalised estimating equations, we estimated the association between a
history of depression and a pregnancy complicated by GDM.
Results: The final analytic population included 121 260 women contributing 128 295
pregnancies, of which 5606 were affected by GDM. A history of depression was significantly
associated with an increased risk of developing GDM (multivariate odds ratio [aOR] = 1.42 [95%
confidence interval (CI) 1.26, 1.60]). Adjusting for pre-pregnancy BMI and weight gain during
pregnancy attenuated the association, although it remained statistically significant (aOR = 1.17
[95% CI 1.03, 1.33]).
Conclusions: A history of depression was significantly associated with an increased GDM risk
among a large multi-ethnic US cohort of women. If the association is confirmed, depression
presents a potentially modifiable risk factor of GDM and provides additional clues to the
underlying pathophysiology of GDM.
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Gestational diabetes mellitus (GDM), a common pregnancy complication, affects
approximately 7–14% of pregnancies in high-risk populations,1 and as high as 18%
according to recent recommendations from the International Association of Diabetes and
Pregnancy Study Groups.2 Over the past several years, the prevalence of GDM has been
increasing.3,4 A pregnancy complicated by GDM is at risk for further complications, such as
preeclampsia, and GDM is related to elevated future risk of type 2 diabetes and
cardiovascular diseases1 after pregnancy. Outside of pregnancy, clinical depression has been
associated with an increased risk for type 2 diabetes,5,6 with evidence for a bidirectional
relationship.7 While few studies have evaluated the association between diabetes and the
onset of perinatal depression,8,9 and there is some evidence that treating GDM reduces the
risk for postpartum depression,10 it is unknown whether a history of depression is associated
with an increased risk of GDM during pregnancy.
Both behavioural and biological theories exist to support the potential association between
depression and GDM. Depression and depressive symptoms are associated with obesity and
behaviours related to the development of type 2 diabetes and GDM, such as excessive
caloric intake, physical inactivity and smoking.11 There are also hypotheses that describe an
underlying biological association between depression and diabetes. Depression can cause
activation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to enhanced and
sustained cortisol secretion. Cortisol opposes the action of insulin, and can lead to visceral
adiposity, insulin resistance and other risk precursors of diabetes.11 Since depression is
common among women of reproductive age,12 it could represent an important and prevalent
risk factor for targeted GDM prevention. We have, therefore, evaluated the association
between a medical history of depression and GDM in the Consortium on Safe Labor (CSL),
a large, multi-ethnic cohort representative of the US population.
Methods
Data for this study came from the CSL, a study initiated by the Eunice Kennedy Shriver
National Institute of Child Health and Human Development, National Institutes of Health, in
collaboration with 12 institutions across the US, and has been described in detail
elsewhere.13 In brief, this was a retrospective cohort study of births between 2002 and 2008
from 19 hospitals representing nine American College of Obstetrics and Gynecology
(ACOG) districts. In total, data from 228 562 deliveries were abstracted from electronic
medical records, including demographic data, medical history, labour and delivery
information, as well as obstetrical, postpartum and neonatal outcomes. Maternal and
newborn discharge International Classification of Diseases (ICD)-9 codes were collected for
each delivery.
Women contributed up to four pregnancies over the course of the study. Exclusion criteria
for the present analyses included multiple gestation pregnancies (n = 5059), missing or
positive medical history of preexisting diabetes (n = 12 771), and deliveries <24 weeks (n =
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395). We excluded one site due to an unrealistic GDM prevalence of <1% (n = 20 725), as
well as participants whose pre-pregnancy body mass index (BMI) data were missing (n = 61
321).
All exposure and outcome data were abstracted from two sources within the electronic
medical records, including the medical chart and discharge record ICD9 codes. ICD9 codes
for depression included 296.2 (major depression, single episode), 296.3 (major depression,
recurrent), 311 (depressive disorder, not otherwise classified), and ICD9 codes for GDM
included 648.8. Both sources of data were combined to assess depression and GDM status
(Figure 1). For example, 2623 cases of GDM were unique to the medical chart, 1109 cases
were unique to the discharge record and 1874 were identified from both sources, for a total
of n = 5606 GDM cases. For medical history of depression, 4230 were unique to the medical
chart, 465 unique to the discharge records and 1120 were identified from both sources, for a
total of n = 5815 instances of depression. A majority of depression cases were acquired from
the medical chart, which did not distinguish between types of depression or whether the
depression was accompanied by other psychiatric conditions. Therefore, we did not make
any distinctions in the analyses. Data on treatment for depression were not available for the
majority of the participants, and all cases were included regardless of treatment.
Means with standard deviations for continuous baseline characteristics, and the number and
proportions for categorical characteristics, were compared between women with and without
history of depression. Due to the large sample size, statistical differences were not tested as
minor, and clinically irrelevant differences would be statistically significant. In multivariate
analyses, the unit of analysis was pregnancy. To account for multiple pregnancies per
woman, generalised estimating equations were employed to estimate the odds ratio (OR) for
GDM, comparing women with and without a history of depression and accounting for
multiple pregnancies per woman. Models adjusted for potential confounding factors that
were selected a priori and included risk factors for depression and GDM, and not in the
causal pathway. These variables included age, race/ethnicity, study site, insurance, parity,
continuous BMI and gestational weight gain (calculated by subtracting the pre-pregnancy
weight from the hospital admission weight). Effect modification was evaluated for age (<25,
25–<30, 30–35 and >35), BMI (<25, 25–29.9 or >30 kg/m2), parity (0, 1, 2, 3 or more) and
race/ethnicity (White, Black, Hispanic, Asian/Pacific Islander, multiracial/other/unknown)
by fitting multiplicative interaction terms of these factors with depression in multivariate
models, and by stratified analyses to determine whether the depression–GDM association
varied across strata of these risk factors. Given the wide range of the prevalence of
depression by study site, we performed additional analyses with subgroups of sites reporting
low (<1–2%) and high (12–17%) prevalence of depression. Sensitivity analyses were
conducted to estimate the bias arising from missing data on BMI. Specifically, baseline
characteristics and age and multivariate ORs describing the association between depression
and GDM were estimated for women with missing and no missing data on BMI. In addition,
to strengthen the temporality assumption, we examined the association limiting the
assessment of depression to the data available in the medical history which was experienced
prior to the current GDM-affected pregnancy. Moreover, we conducted sensitivity analyses
to differentiate the effect history of major depression from that of postpartum depression by
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restricting the analysis to nulliparous women. All statistical analyses were performed using
SAS 9.1 (Cary, NC, USA).
Results
The final analytic population included 121 260 women including 128 295 pregnancies, of
which 5606 were cases of GDM. The age range of women included in the study was 12–58
years. Women with history of depression were heavier [pre-pregnancy BMI (26.9 vs. 25.1
kg/m2)] and were more likely to have GDM (5.4% vs. 4.3%). They gained slightly less
weight during pregnancy than women with no reported history of depression (13.8 vs. 14.2
kg) (Table 1). Non-Hispanic White women reported the highest frequency of depression
(5.8%) compared with non-Hispanic Black (3.9%), Hispanic (3.0%), Asian (0.8%) and
multiracial/other/unknown race women (2.6%). The frequency of reported depression also
increased with increasing parity (from 3.4% for nulliparous women to 6.2% for women with
three or more pregnancies). In addition, no significant differences on distributions of major
baseline characteristics in the entire analytical population were observed from those with
missing data on pre-pregnancy BMI.
The age-adjusted OR for GDM comparing women with a medical history of depression to
women without a medical history of depression was 1.30 [95% CI 1.16, 1.47] (Table 2).
Controlling for age, study site, race/ethnicity and parity, as well as the type of medical
insurance (to address socio-economic differences among women, and as a proxy for access
to psychiatric and prenatal care), strengthened the association, aOR = 1.42 [95% CI 1.26,
1.60]. However, adjusting for continuous pre-pregnancy BMI and gestational weight gain
attenuated the results, although they remained significant, aOR = 1.17 [95% CI 1.03, 1.33].
Moreover, the association persisted across sites with high vs. low prevalence of depression,
and between nulliparous and multiparous women. Moreover, when the analysis was limited
to depression abstracted only from medical record where depression was experienced prior
to the current GDM-affected pregnancy, the results were comparable (Table 2).
It appears that there was a significant interaction between pre-pregnancy BMI and
depression (P = 0.02). Across categories of BMI, the OR associating depression and GDM
was ≤20 kg/m2: aOR = 1.48 (0.85, 2.55); 20–24.9 kg/m2: 1.11 (0.86, 1.44); 25–30 kg/m2:
1.32 (1.05, 1.66); and >30: 1.11 (0.92, 1.33). No significant interactions between depression
and age or race were identified (P > 0.05).
Comment
In this large, population-based, multi-ethnic cohort of US population, sampled from each of
the nine ACOG districts, we identified a significantly increased odds of GDM associated
with a medical history of depression. The association remained significant even after
adjustment for pre-pregnancy BMI and was robust to several sensitivity analyses. Although
BMI remains the strongest risk factor for identifying women at high risk for GDM,
depression may represent an independent and novel risk factor for identifying women at
high risk and help us further understand the underlying pathophysiology.
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We are unaware of prior studies evaluating the association between depression and the onset
of GDM. However, our results are in line with several studies that have evaluated the
association between depression and type 2 diabetes.5–7 While there is evidence for a
bidirectional association, the effect appears to be larger for the risk of diabetes following
depression (pooled relative risk across 13 studies was 1.60 [95% CI 1.37, 1.88]).6
Depression is a prevalent public health issue with significant medical, emotional and
economic burden. It affects 2.3–4.9% of the population at any given time14 and 13.3–17.1%
of individuals over a lifetime.14 Women are disproportionately affected, having around two
times the lifetime prevalence of major depression compared with men,15 and the onset of
symptoms often occurs during the reproductive years.16 There is evidence that up to 25% of
women experience depression or depressive symptoms during pregnancy.17 If depression
leads to GDM, it could represent an important and prevalent risk factor for targeted
prevention strategies. In addition, depression may be associated with other metabolic
conditions, such as obesity,18 the major risk factor for GDM, as well as metabolic
syndrome.19
Several biologically plausible pathways have been suggested to describe the association
between depression and glucose intolerance.11 Depression has long been implicated in
elevating cortisol following activation of the HPA axis.20,21 Cortisol is a counter-regulatory
hormone, which is a hormone that opposes the action of insulin. Prolonged exposure to
cortisol can, therefore, lead to visceral adiposity, insulin resistance, dyslipidemia and
hypertension,11 each implicated in the pathology of GDM. During the course of pregnancy,
urinary cortisol levels increase along with the upregulation of the maternal HPA axis,22 and
may in fact regulate metabolic changes, such as increases in body weight and metabolic rate,
that lead to insulin resistance in pregnancy.23 Exacerbating these high cortisol levels could,
in turn, increase the metabolic consequences that contribute to GDM pathogenesis.
Additional pathways include catecholamine release due to an enhanced sympathetic nervous
system response or an inflammatory response, which also contributes to insulin resistance.11
There are several strengths to this study. It utilises a large cohort, representative of multiple
race/ethnicities of women throughout the US. In addition, we were able to establish a
reasonable assumption of temporality by conducting sensitivity analyses, limiting the
assessment of depression to data available in the medical history where depression was
experienced prior to the current GDM-affected pregnancy. There are also potential
limitations. First, the temporal relationship between pre-pregnancy BMI and depression is
not clear in this dataset so that we are unable to conclusively determine whether BMI is a
confounder (common cause of depression and GDM), mediator (caused by depression and a
cause of GDM), effect modifier or a combination. For the analyses, we made the assumption
that pre-pregnancy BMI represents a lifetime weight burden and would predate depression,
and therefore present models adjusted for BMI. Nonetheless, even if BMI is a mediator, the
importance of identifying depression and the subsequent metabolic consequences remains.
Although determining the exact causal relationship is beyond the scope of the CSL data,
depression may work through direct pathways, or indirectly through BMI, and remains an
important avenue for identification of women at risk for GDM.
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Although a validation study determined that mapping data from electronic medical records
to an analytic dataset was a highly valid process comparable to abstraction undertaken by
hand,13 data on medical history of depression and GDM were not explicitly validated. We
observed that the depression prevalence varied across sites. However, regardless of the level
of reporting, the significant association between depression and GDM remained. Third, for a
large per cent of participants, data on pre-pregnancy BMI were missing; however, the
prevalence of a history of depression, race, type of insurance coverage, parity or GDM did
not vary appreciably between women with and without missing data. Therefore, reporting of
BMI was not dependent on risk factors for either depression or GDM, and we believe it is
unlikely to have biased our results. We did not have information on potentially important
covariates, including physical activity, smoking and dietary factors, or treatment of
depression.
In conclusion, we identified a significant association between a medical history of
depression and the onset of GDM in a large, population-based, multi-ethnic cohort of US
women. Depression is a common condition among women of reproductive age. If confirmed
in future studies, this may represent a novel risk factor for identifying women at high risk
and to potentially provide novel clues to the underlying pathophysiology of GDM.
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Assessment of depression and gestational diabetes mellitus (GDM) from the medical chart
and the discharge records.
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 of individuals with and without a medical history of depression among 128







(n = 122 480)
Gestational diabetes 313 (5.4) 5293 (4.3)
Maternal age, years 27.6 (6.1) 27.8 (6.1)
Height, m 1.6 (0.1) 1.6 (0.1)
Pre-pregnancy weight, kg 72.3 (20.0) 67.3 (16.9)
Weight gain, lbs 13.8 (7.8) 14.2 (6.6)
BMI, kg/m2 26.9 (7.0) 25.1 (6.0)
 <25 (%) 2820 (48.5) 74 015 (60.4)
 ≥25 and <30 (%) 1438 (24.7) 27 353 (22.3)
 ≥30 (%) 1557 (26.8) 21 112 (17.2)
Race (%)
 Non-Hispanic White 4000 (68.8) 65 459 (53.4)
 Non-Hispanic Black 858 (14.8) 21 317 (17.4)
 Hispanic 721 (12.4) 23 594 (19.3)
 Asian/Pacific Islander 36 (0.6) 4596 (3.8)
 Multiracial/other/unknown 200 (3.4) 7513 (6.1)
Parity (%)
 0 1730 (29.9) 49 817 (40.7)
 1 1803 (31.0) 36 674 (29.9)
 2 1209 (30.8) 20 002 (16.3)
 3 or more 1064 (18.3) 15 987 (13.1)
Insurance (%)
 Private 3252 (55.9) 67 323 (55.0)
 Public 2291 (39.4) 33 584 (27.4)
 Self-pay 90 (1.6) 1139 (0.9)
 Other/unknown 182 (3.1) 20 434 (16.7)
a
Data presented in the table are mean (standard deviation) unless otherwise specified.
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Table 2
Age- and multivariate-adjusted odds ratios (OR) and 95% confidence intervals (CI) describing the association






Sites reporting a low
prevalence of depression
n 5606 5098 860 2317
N 128 295 111 952 16 072 47 297
Unadjusted 1.26 [1.12, 1.42] 1.23 [1.10, 1.40] 1.23 [1.00, 1.45] 1.53 [1.05, 2.24]
a
aOR I [95% CI]
1.30 [1.16, 1.47] 1.21 [1.07, 1.36] 1.23 [1.02, 1.48] 1.55 [1.05, 2.27]
b
aOR II [95% CI]
1.42 [1.26, 1.60] 1.36 [1.20, 1.54] 1.27 [1.05, 1.53] 1.58 [1.07, 2.34]
c
aOR III [95% CI]
1.17 [1.03, 1.33] 1.15 [1.01, 1.31] 1.21 [0.98, 1.49] 1.28 [0.85, 1.94]
a
aOR I: adjusts for age.
b
aOR II: additionally adjusts for race/ethnicity, study site, insurance, parity.
c
aOR III: additionally adjusts for pre-pregnancy BMI (continuous) and gestational weight gain.
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